← Back to Search

Insulin

Lyumjev for Type 1 Diabetes

Phase 1
Waitlist Available
Research Sponsored by Eli Lilly and Company
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up predose up to 240 minutes postdose
Awards & highlights

Study Summary

This trial will compare the effects of two different insulin treatments on blood sugar levels during exercise in people with type 1 diabetes. It will last up to 10 weeks and include up to 7 visits.

Eligible Conditions
  • Type 1 Diabetes

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~predose up to 240 minutes postdose
This trial's timeline: 3 weeks for screening, Varies for treatment, and predose up to 240 minutes postdose for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change From Baseline in Plasma Glucose (PG) From the Start to the End of Exercise for Each Treatment Arm
Secondary outcome measures
Change From Baseline in Postprandial Plasma Glucose (PPG) Excursion During Mixed-Meal Tolerance Test (MMTT) for Each Treatment Arm

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: LyumjevExperimental Treatment1 Intervention
Lyumjev administered subcutaneously (SC) during a meal and following different approaches for basal reduction prior to exercise
Group II: HumalogActive Control1 Intervention
Humalog administered SC during a meal and following different approaches for basal reduction prior to exercise
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Lyumjev
2022
Completed Phase 1
~30

Find a Location

Who is running the clinical trial?

Eli Lilly and CompanyLead Sponsor
2,624 Previous Clinical Trials
3,216,896 Total Patients Enrolled
Study DirectorEli Lilly and Company
1,349 Previous Clinical Trials
415,655 Total Patients Enrolled
~8 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top